LEMD1 anticorps (Middle Region)
Aperçu rapide pour LEMD1 anticorps (Middle Region) (ABIN1450098)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, Mouse.
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogène
- 19 amino acid synthetic peptide near the center of Human LEMD1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- LEMD1 (LEM Domain Containing 1 (LEMD1))
-
Autre désignation
- LEMD1
-
Sujet
- LEMD1 (LEM domain-containing1) is a member of cancer-testis gene family. LEMD1 is normally expressed only in testis. Six alternatively spliced forms of LEMD1 transcripts in normal testis have been identified, but only one of the six was expressed in colorectal cancers. LEMD1 may represent a promising target antigen for immunotherapy of colorectal cancers. In addition, LEMD1 and SPATA19 are putative cancer biomarkers and promising targets for active immunotherapy.Synonyms: CT50, Cancer, LEM domain containing 1, LEMP-1, testis antigen 50
-
ID gène
- 93273
-
UniProt
- Q68G75
Antigène
-